What is Silo Pharma?
Silo Pharma Inc. is a developmental stage biopharmaceutical company dedicated to creating innovative treatments for conditions with significant unmet needs. Their therapeutic focus spans PTSD, stress-induced psychiatric disorders, chronic pain, and central nervous system (CNS) diseases. The company's approach involves developing both conventional drug formulations and specialized psychedelic formulations, positioning them at the forefront of emerging therapeutic modalities.
How much funding has Silo Pharma raised?
Silo Pharma has raised a total of $4.3M across 1 funding round:
Share Placement
$4.3M
Share Placement (2021): $4.3M, investors not publicly disclosed
What's next for Silo Pharma?
The recent major enterprise-level funding and strategic investment indicate a pivotal growth phase for Silo Pharma. This capital infusion is expected to accelerate the company's research and development pipeline, potentially enabling further clinical trials and the advancement of their novel therapeutic candidates toward market approval. The strategic nature of the investment suggests a strong alignment with the company's long-term vision and market potential in addressing complex neurological and psychiatric conditions.
See full Silo Pharma company page
